Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
Sales | 188,121 | 118,718 | 100,741 | 132,641 | 129,631 |
Cost of Goods | 78,349 | 61,096 | 66,541 | 84,299 | 70,744 |
Gross Profit | 109,772 | 57,622 | 34,200 | 48,342 | 58,887 |
Operating Expenses | 56,185 | 49,487 | 50,973 | 48,835 | 53,863 |
Operating Income | 53,936 | 8,231 | -16,232 | -194 | 5,768 |
Interest Expense | -93 | 65 | 41 | 50 | 45 |
Other Income | 396 | 464 | 438 | 264 | 3,312 |
Pre-tax Income | 54,425 | 8,630 | -15,835 | 20 | 9,035 |
Income Tax | 19,354 | 2,205 | -6,213 | 200 | 3,416 |
Net Income Continuous | 35,071 | 6,425 | -9,622 | -180 | 5,619 |
Net Income | $35,071 | $6,425 | $-9,622 | $-180 | $5,619 |
EPS Basic Total Ops | 0.52 | 0.09 | -0.16 | 0.00 | 0.08 |
EPS Basic Continuous Ops | 0.52 | 0.09 | -0.15 | 0.00 | 0.08 |
EPS Diluted Total Ops | 0.50 | 0.09 | -0.16 | 0.00 | 0.08 |
EPS Diluted Continuous Ops | 0.50 | 0.09 | -0.15 | 0.00 | 0.08 |
EBITDA(a) | $62,224 | $16,246 | $-10,708 | $6,109 | $17,550 |